Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Boris Yagen"'
Autor:
Pishan Chang, Benoit Orabi, Rania M. Deranieh, Manik Dham, Oliver Hoeller, Jakob A. Shimshoni, Boris Yagen, Meir Bialer, Miriam L. Greenberg, Matthew C. Walker, Robin S. B. Williams
Publikováno v:
Disease Models & Mechanisms, Vol 5, Iss 1, Pp 115-124 (2012)
SUMMARY Valproic acid (VPA) is the most widely prescribed epilepsy treatment worldwide, but its mechanism of action remains unclear. Our previous work identified a previously unknown effect of VPA in reducing phosphoinositide production in the simple
Externí odkaz:
https://doaj.org/article/d203726140b3427493440a80b9c53ea0
Publikováno v:
Journal of food protection. 52(8)
A promising method for the destruction of aflatoxin B
Publikováno v:
Epilepsy & Behavior. 49:298-302
sec-Butylpropylacetamide (SPD) is a one-carbon homologue of valnoctamide (VCD), a chiral constitutional isomer of valproic acid's (VPA) corresponding amide--valpromide. Racemic-SPD and racemic-VCD possess a unique and broad-spectrum antiseizure profi
Publikováno v:
Clinical Biochemistry. 46:1532-1537
Purpose To determine the cytotoxicity of valproic acid (VPA) and its derivatives in human hepatoblastoma (HepG2) cells, and to study the possible toxicity of these compounds in human lymphocytes from patients with known hypersensitivity syndrome reac
Publikováno v:
Epilepsia. 54:99-102
Summary sec-Butyl-propylacetamide (SPD) is a one-carbon homolog of valnoctamide (VCD), a chiral constitutional isomer of valproic acid's (VPA) corresponding amide valpromide. VCD has potential as a therapy in epilepsy including status epilepticus (SE
Autor:
Meir Bialer, Wendy A. Pouliot, K. Ricks, C. Nelson, Tawfeeq Shekh-Ahmad, F.E. Dudek, Naama Hen, Boris Yagen, Bonnie Roach, Dan Kaufmann
Publikováno v:
Neuroscience. 231:145-156
Better treatment of status epilepticus (SE), which typically becomes refractory after about 30 min, will require new pharmacotherapies. The effect of sec-butyl-propylacetamide (SPD), an amide derivative of valproic acid (VPA), on electrographic statu
Autor:
H. Steve White, Misty D. Smith, Kevin C. Brennan, Marshall Devor, Meir Bialer, Dan Kaufmann, Boris Yagen, Peter J. West
Publikováno v:
Pharmacological research. 117
Chronic pain is a multifactorial disease comprised of both inflammatory and neuropathic components that affect ∼20% of the world's population. sec-Butylpropylacetamide (SPD) is a novel amide analogue of valproic acid (VPA) previously shown to posse
Publikováno v:
Journal of Medicinal Chemistry. 55:2835-2845
A novel class of 19 carbamates was synthesized, and their anticonvulsant activity was comparatively evaluated in the rat maximal electroshock (MES) and subcutaneous metrazol (scMet) seizure tests and pilocarpine-induced status epilepticus (SE) model.
Autor:
James P. Stables, Naama Hen, John H. McDonough, Amanda L. Pollock, H. Steve White, Dan Kaufmann, Anitha Alex, Karen S. Wilcox, Meir Bialer, Boris Yagen, Tawfeeq Shekh-Ahmad
Publikováno v:
Epilepsia. 53:134-146
Purpose sec-Butyl-propylacetamide (SPD) is a one-carbon homologue of valnoctamide (VCD), a CNS-active amide derivative of valproic acid (VPA) currently in phase II clinical trials. The current study evaluated the anticonvulsant activity of SPD in a b
Autor:
Andrea Scozzafava, Boris Yagen, Robert McKenna, Claudiu T. Supuran, Naama Hen, Alfonso Maresca, Mayank Aggarwal, Arthur H. Robbins, Meir Bialer
Publikováno v:
Journal of Medicinal Chemistry; Vol 54
Aromatic amides comprising branched aliphatic carboxylic acids and 4-aminobenzenesulfonamide were evaluated for their inhibition of carbonic anhydrase (CA) isoforms. Of the most anticonvulsant-active compounds (2, 4, 13, 16, and 17), only 13, 16, and